IOL Chemicals and Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹2,587cr+8.6% on Mar 2025
Shareholders' equity: ₹1,799cr+6.6% on Mar 2025
Total debt: ₹132cr+12.8% on Mar 2025
Cash and investments: ₹68.9cr−15.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,165	1,158	922	751
	93.6	20.8	99.8	81.4
	—	—	17.4	—
	12.8	12.3	11.6	0.7
	1.9	1.1	1.0	8.2
	17.4	17.4	0.0	17.4
	45.1	7.9	48.9	234
	62.5	25.3	48.9	251
	23.1	12.8	24.4	9.2
	1,359	1,231	1,125	1,102
	371	361	425	326
	3.5	3.3	2.9	2.6
	603	514	471	505
	65.4	78.2	7.7	1.4
	133	130	135	20.4
	7.5	5.6	7.1	22.4
	812	731	624	552
	44.1	59.6	64.1	41.1
	1,228	1,151	1,120	920
	2,587	2,382	2,244	2,022
Equity
	58.7	58.7	58.7	58.7
	1,740	1,629	1,553	1,449
	1,799	1,688	1,612	1,508
	1,799	1,688	1,612	1,508
Liabilities
	2.4	—	0.0	—
	2.4	0.0	0.0	0.0
	11.0	6.7	6.7	1.7
	84.9	77.8	66.1	56.4
	—	—	0.0	0.1
	98.2	84.5	72.9	58.2
	132	117	32.8	79.6
	483	428	469	314
	51.8	46.3	37.8	36.5
	666	591	540	430
	3.4	2.0	3.4	8.1
	2.4	—	0.0	—
	18.1	17.1	16.9	17.8
	690	610	560	456
	788	694	633	514
	2,587	2,382	2,244	2,022
Assets — additional as-filed lines
	—	0.3	6.8	1.8
Trade payables — MSME split
	7.3	6.7	—	—
	475	421	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IOLCP₹180.62

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersMOREPENLAB FDC INNOVACAP ORCHPHARMA SENORES SANOFI GUJTHEM RPGLIFEMcap ₹5,302 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	751.0	921.6	1,158.4	1,165.4	1,165.4
+ Capital Work-in-Progress	81.4	99.8	20.8	93.6	93.6
+ Investment Property	—	17.4	—	—	—
+ Other Intangibles	0.7	11.6	12.3	12.8	12.8
+ Intangibles under Development	8.2	1.0	1.1	1.9	1.9
+ Non-current Investments	17.4	0.0	17.4	17.4	17.4
+ Other Non-current Financial Assets	233.9	48.9	7.9	45.1	45.1
Non-current Financial Assets	251.3	48.9	25.3	62.5	62.5
+ Other Non-current Assets	9.2	24.4	12.8	23.1	23.1
Total Non-current Assets	1,101.7	1,124.6	1,230.7	1,359.3	1,359.3
Current Assets
+ Inventories	325.5	424.8	360.6	371.1	371.1
+ Current Investments	2.6	2.9	3.3	3.5	3.5
+ Trade Receivables	505.3	471.2	513.7	603.1	603.1
+ Cash & Cash Equivalents	1.4	7.7	78.2	65.4	65.4
+ Other Bank Balances	20.4	135.2	130.0	133.0	133.0
+ Other Current Financial Assets	22.4	7.1	5.6	7.5	7.5
Current Financial Assets	552.1	624.1	730.8	812.5	812.5
+ Other Current Assets	41.1	64.1	59.6	44.1	44.1
Total Current Assets	920.4	1,119.8	1,151.3	1,227.6	1,227.6
Total Assets	2,022.1	2,244.4	2,382.1	2,587.0	2,587.0
Equity
+ Equity Share Capital	58.7	58.7	58.7	58.7	58.7
+ Other Equity / Reserves	1,449.0	1,552.8	1,629.0	1,739.8	1,739.8
Equity — Owners of Parent	1,507.7	1,611.5	1,687.7	1,798.6	1,798.6
Total Equity	1,507.7	1,611.5	1,687.7	1,798.6	1,798.6
Liabilities
+ Other Non-current Financial Liab	—	0.0	—	2.4	2.4
Non-current Financial Liabilities	0.0	0.0	0.0	2.4	2.4
+ Provisions — Non-current	1.7	6.7	6.7	11.0	11.0
+ Deferred Tax Liabilities	56.4	66.1	77.8	84.9	84.9
+ Other Non-current Liabilities	0.1	0.0	—	—	—
Non-current Liabilities	58.2	72.9	84.5	98.2	98.2
+ Borrowings — Current	79.6	32.8	117.0	132.0	132.0
+ Trade Payables	314.2	469.2	427.6	482.6	482.6
+ Other Current Financial Liab	36.5	37.8	46.3	51.8	51.8
Current Financial Liabilities	430.4	539.7	590.9	666.3	666.3
+ Provisions — Current	8.1	3.4	2.0	3.4	3.4
+ Current Tax Liabilities	—	0.0	—	2.4	2.4
+ Other Current Liabilities	17.8	16.9	17.1	18.1	18.1
Current Liabilities	456.3	560.0	609.9	690.2	690.2
Total Liabilities	514.4	632.9	694.4	788.4	788.4
Total Equity & Liabilities	2,022.1	2,244.4	2,382.1	2,587.0	2,587.0
Assets — additional as-filed lines
+ Current Tax Assets	1.8	6.8	0.3	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	6.7	7.3	7.3
+ Dues to Other Creditors — Current	—	—	420.8	475.3	475.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.